Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1997; 77(03): 605-606
DOI: 10.1055/s-0038-1656016
DOI: 10.1055/s-0038-1656016
Letter to the Editor
An Alternative Method for PAI-1 Promoter Polymorphism (4G/5G) Typing
Further Information
Publication History
Received 20 September 1996
Accepted after revision 14 November 1996
Publication Date:
11 July 2018 (online)
-
References
- 1 Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-1079
- 2 Ridker PM, Hennekens CH, Stampfer MJ, Manson J, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994; 343: 0940-0943
- 3 Chandler WL, Trimble SL, Loo SC, Mornin D. Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (tPA) and tPA/PAI-1 complex in plasma. Blood 1990; 76: 0930-0937
- 4 Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993; 268: 10739-10745